Compare HDFC Pharma And Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.1
1.87
NAV
₹17.22
₹37.17
Fund Started
14 Sep 2023
25 Jun 2018
Fund Size
₹2030.81 Cr
₹6801.16 Cr
Exit Load
Exit load of 1%, if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
13.00%
6.26%
3 Year
-
25.06%
5 Year
-
15.70%
Equity
98.22%
97.98%
Cash
1.78%
1.99%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 9.81% |
Divi's Laboratories Ltd. | 8.38% |
Glenmark Pharmaceuticals Ltd. | 6.62% |
Lupin Ltd. | 6.44% |
Max Healthcare Institute Ltd. | 6.36% |
Alkem Laboratories Ltd. | 6.21% |
Aster DM Healthcare Ltd. | 5.42% |
Ipca Laboratories Ltd. | 4.80% |
Anthem Biosciences Ltd. | 4.46% |
Fortis Healthcare Ltd. | 4.02% |
Sun Pharmaceutical Industries Ltd. | 11.21% |
Cipla Ltd. | 9.40% |
Mankind Pharma Ltd. | 7.64% |
Dr. Reddy's Laboratories Ltd. | 6.52% |
Biocon Ltd. | 6.20% |
Divi's Laboratories Ltd. | 5.95% |
Lupin Ltd. | 3.99% |
Aurobindo Pharma Ltd. | 3.70% |
Alkem Laboratories Ltd. | 3.47% |
Syngene International Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
14 Sep 2023
25 Jun 2018
